Global Stem Cell Therapy Market to Grow with a CAGR of 12.39% through 2028

Increasing technological advancement in stem cell therapeutics and surging demand for stem cell therapy is expected to drive the global stem cell therapy market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Global Stem Cell Therapy Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Stem Cell Therapy Market stood at USD 261.07 Million in 2022 and is anticipated to grow with a CAGR of 12.39% in the forecast period, 2024-2028. In recent years, there has been a noticeable increase in the interest of pharmaceutical companies in stem cell therapy and collaboration with biotechnology companies. This is driven by the growing need for improved treatment solutions for cardiac, neurological, and autoimmune disorders, resulting in a surge in research and development activities in this market. Moreover, the growing awareness of promising stem cell therapies for severe disorders has contributed to the expansion of the stem cell therapy market. Additionally, start-ups have entered the market and are making a significant impact in the field of stem cell therapeutics.

Regulatory authorities in various countries have taken steps to establish clear pathways for the development and commercialization of stem cell therapies, while ensuring patient safety. These evolving regulatory frameworks aim to strike a balance between innovation and safety, while also addressing ethical concerns.

Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on "Global Stem Cell Therapy Market.”

Significant investments have been made in stem cell therapy research for over 50 years, owing to its unique property of dividing and replicating multiple times. The versatility of stem cells to differentiate into various tissue types makes them suitable for use in regenerative medicine. Notably, embryonic stem cells have the potential to form new organs. However, it is important to note that the majority of stem cell therapies are still in the research phase, with only a few treatments having gained approval from regulatory bodies. Furthermore, specific criteria must be met before a patient can undergo these treatments.

Market players are increasing their investments in oncology to provide better clinical solutions for cancer patients. Despite the effectiveness of chemotherapy in treating cancer, it is associated with serious side effects that can compromise the patient's bone marrow and overall well-being. To overcome these challenges and improve the life expectancy of cancer patients, researchers are actively exploring the potential of stem cell therapy. Additionally, novel therapies for cardiac problems, arthritis, diabetes, spinal cord injury, autoimmune disorders, and other conditions are also being discovered.

The growth of the stem cell therapy market is expected to be driven by accelerated funding for stem cell therapies. The continuous interest of investors in stem cell-based therapeutics, particularly due to the introduction of innovative therapies that offer effective treatments for various fatal disorders, is a significant factor propelling market growth.

Due to their high population, developing nations experience a significant burden of chronic diseases, leading to an increasing demand for treatment in these regions. Notably, the prevalence of Alzheimer's disease has shown a substantial rise in North America, particularly in the United States, where it is projected that the number of affected individuals will reach 8.4 million by 2030. This trend contributes to the growth of the market, driven by the escalating rates of chronic diseases.

The growing awareness of therapies utilizing stem cells has fueled demand for innovation and system development. Market players are actively seeking collaborations to enhance research and development efforts, aiming to expand the stem cell treatment market in both developing and developed nations in the near future. Increased funding has been allocated to further research in cell-based approaches. The demand for induced pluripotent stem cells, which involves the genetic reprogramming of adult human stem cells to acquire embryonic-like properties, is on the rise. This approach proves to be a promising alternative to embryonic stem cells in the market. Limited awareness and ethical concerns surrounding embryonic stem cell treatment are among the factors impeding market growth. For example, data from the National Center for Biotechnology Information highlights key concerns such as fear of unfamiliar therapies and insufficient knowledge of available treatment options among the population. Additionally, high therapy costs contribute to decreased adoption rates, posing a challenge to market expansion.

The Global Stem Cell Therapy Market is segmented into type, cell source, application, end user, regional distribution, and company.

Based on type, the market is segmented into allogenic transplants and autologous transplants. The allogenic therapy segment accounted for the largest market share. Factors such as high pricing and the growth of stem cell banking have contributed to the expansion of this segment. Furthermore, numerous cell therapy companies are shifting their focus towards the development of allogenic cell therapy products, leading to significant growth in this sector.

Moreover, key market players are undertaking strategic activities to strengthen their product portfolio, creating lucrative opportunities in the foreseeable future. For instance, in March 2021, Acepodia announced the successful closure of its USD 47 million Series B financing to advance the pipeline of allogenic cell therapy candidates. Additionally, in June 2022, Immatics and Bristol Myers Squibb expanded their strategic alliance to further develop gamma delta allogeneic cell therapy programs. However, autologous therapy is expected to experience a favorable growth rate throughout the forecast period. This can be attributed primarily to the low risk of complications associated with autologous treatment. Other factors that are anticipated to drive the growth of this segment include affordability, improved patient survival rates, the elimination of the need for identifying an HLA-matched donor, and the absence of graft-versus-host diseases. Furthermore, autologous MSCs are being investigated for their potential in the treatment of osteoarthritis, as they have the ability to differentiate into cartilage and bone tissues.

Based on region, North America segment is expected to grow during the forecast period.  The region's strong biotechnology industry, presence of key players, extensive R&D, and promotion of personalized medicines have resulted in higher market penetration. Furthermore, the region leads in revenue share due to its government initiatives for promoting stem cell therapies. For example, in March 2020, the government of Canada invested approximately USD 6.9 million in regenerative medicine and stem cell research, supporting 9 transnational projects and 4 clinical trials to foster growth in the regenerative medicine sector.

Meanwhile, Asia Pacific is projected to experience rapid growth with a CAGR of 16.09% during 2023-2030. This growth is attributed to the region's strong product pipelines of stem cell-based therapies and a significant patient population base. The increasing incidence rate of diseases such as cancer, neurological disorders, and diabetes fuels the demand for stem cell therapies. Moreover, government funding aimed at accelerating stem cell research further reinforces the growth prospects in this region.

Major companies operating in Global Stem Cell Therapy Market are:

• Biorestorative Therapies Inc.
• Celgene corporation
• ReNeuron Group plc
• Opexa Therapeutics, Inc.
• Pluristem Therapeutics Inc
• STEMCELL Technologies Inc.
• Biovault family
• Precious Cells International Ltd
• Mesoblast Ltd
• Seneca Biopharmaceuticals, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“There is significant global anticipation for the potential of stem cell-based therapies due to their proven safety and effectiveness. Stem cells have garnered attention in the field of regenerative medicine, offering immense possibilities for healing and replacing damaged tissues and organs. As a highly promising cell source, stem cells continue to attract increased attention from researchers, clinicians, and scientists. The market growth of stem cell therapies is driven by various factors, including burgeoning collaborations, robust funding, government initiatives, and extensive research and development.

To expand their market presence, key players in this industry are adopting a range of organic and inorganic strategies such as partnerships, mergers and acquisitions, geographical expansion, and strategic collaborations. For example, in January 2021, Celularity Inc. and GX Acquisition Corp. entered into a merger agreement to accelerate the development and production of innovative allogeneic cell therapies, including CAR T cell therapies derived from the postpartum placenta and genetically modified natural killer (NK) cell therapies. Furthermore, the growing recognition of precision medicines is further bolstering the market growth. Scientists are exploring novel procurement methods that can be leveraged for the development of personalized medicines. Therefore, with the application of these cells, coupled with strategic initiatives by market players, the development of potential personalized medicines is on the horizon.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Allogenic Transplants, Autologous Transplants), By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), By Application (Cancer, Musculoskeletal Disorder, Wounds and Injuries, Cardiovascular Disease, Others), By End User (Hospitals and Surgical Centers, Therapeutic Companies), By Region and Competition”, has evaluated the future growth potential of Global Stem Cell Therapy Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Stem Cell Therapy Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York  10017

Tel: +1-646-360-1656

Email: [email protected]